1.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 0507000369, NCT00337987
|
|
2.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 15232B, NCT00515528
|
|
3.
|
Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 200541, NCT00703105
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 200732, NCT00726037
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: E7272-701, NCT01127451
|
|
6.
|
Phase: Phase I Type: Treatment Status: Active Age: 4 to 55 Sponsor: NCI, Other Protocol IDs: UPCC 04511, NCT01343043
|
|
7.
|
Phase: Phase I Type: Treatment Status: Active Age: 20 to 79 Sponsor: Pharmaceutical / Industry Protocol IDs: E7777-J081-101, NCT01401530
|
|
8.
|
Phase: No phase specified Type: Natural history/Epidemiology, Tissue collection/Repository Status: Active Age: 18 and over Sponsor: Other Protocol IDs: IRB 0509084, NCT00254332
|